Lishan Aklog Lucid Diagnostics Inc. (LUCD) insider trading activity

LUCD Quotes by TradingView

Lishan Aklog is Chief Executive Officer of Lucid Diagnostics Inc.. Currently has a direct ownership of 1.47 Million shares of LUCD, which is worth approximately $1.99 Million. The most recent transaction as insider was on Feb 20, 2025, when has been sold 300,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.47M
25.72% 3M change
134.89% 12M change
Total Value Held $1.99 Million

Lishan Aklog Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2025
BUY
Grant, award, or other acquisition
-
300,000 Added 16.98%
1,466,627 Common Stock
May 07 2024
BUY
Grant, award, or other acquisition
-
400,000 Added 25.53%
1,166,627 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
60,000 Added 8.77%
624,400 Common Stock

Also insider at

VHAQ-UN
Viveon Health Acquisition Corp. ETFs
Director
PAVM
PAVmed Inc. Healthcare
Chairman and CEO
CFRX
CONTRAFECT Corp Healthcare
Director
LA

Lishan Aklog

Chief Executive Officer
Norcross, GA

Track Institutional and Insider Activities on LUCD

Follow Lucid Diagnostics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUCD shares.

Notify only if

Insider Trading

Get notified when an Lucid Diagnostics Inc. insider buys or sells LUCD shares.

Notify only if

News

Receive news related to Lucid Diagnostics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LUCD